Company Filing History:
Years Active: 1985-1998
Title: Dae Y Cha: Innovator in Pharmaceutical Chemistry
Introduction
Dae Y Cha is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on improving pharmaceutical formulations and processes, which has implications for drug efficacy and patient experience.
Latest Patents
One of Dae Y Cha's latest patents is related to fine-beaded colestipol hydrochloride and pharmaceutically elegant dosage forms. This invention enhances the emulsion copolymerization process for preparing fine-beaded colestipol hydrochloride (FBCH). The improvement involves utilizing a specific weight ratio of water to polyethylenepolyamine and a weight ratio of surfactant to polyethylenepolyamine. The resulting product is a novel fine-beaded form of a known pharmaceutical composition, yielding non-gritty oral powders and tablets that exhibit increased potency.
Another significant patent involves a mercury removal process. This process purifies oxymercuration reaction products and mercury-contaminated steroids by dissolving the compound in a suitable solvent and contacting it with metal dust, such as zinc, copper, or iron, along with a suitable acid. This innovation addresses critical safety concerns in pharmaceutical manufacturing.
Career Highlights
Dae Y Cha has worked with prominent companies in the pharmaceutical industry, including The Upjohn Company and Pharmacia & Upjohn Company. His experience in these organizations has contributed to his expertise in drug formulation and development.
Collaborations
Dae Y Cha has collaborated with various professionals in his field, including Verlan H Van Rheenen. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical chemistry.
Conclusion
Dae Y Cha's contributions to pharmaceutical chemistry through his patents and career experiences highlight his role as an innovator in the industry. His work continues to impact the development of more effective and patient-friendly pharmaceutical products.